126 related articles for article (PubMed ID: 36273189)
1. Dexmedetomidine alleviates inflammatory response and oxidative stress injury of vascular smooth muscle cell via α2AR/GSK-3β/MKP-1/NRF2 axis in intracranial aneurysm.
Zhang Z; Mu X; Zhou X
BMC Pharmacol Toxicol; 2022 Oct; 23(1):81. PubMed ID: 36273189
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor.
Sha J; Zhang H; Zhao Y; Feng X; Hu X; Wang C; Song M; Fan H
Toxicol Appl Pharmacol; 2019 Feb; 364():144-152. PubMed ID: 30597158
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine ameliorates lipopolysaccharide-induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK-3β/Nrf2 signaling pathway.
Feng X; Guan W; Zhao Y; Wang C; Song M; Yao Y; Yang T; Fan H
J Cell Physiol; 2019 Aug; 234(10):18994-19009. PubMed ID: 30919976
[TBL] [Abstract][Full Text] [Related]
4. The SNHG12/microRNA-15b-5p/MYLK axis regulates vascular smooth muscle cell phenotype to affect intracranial aneurysm formation.
Feng W; Liang H; Liu D; Ruan S
Microvasc Res; 2024 Mar; 152():104643. PubMed ID: 38081409
[TBL] [Abstract][Full Text] [Related]
5. Nrf-2 signaling inhibits intracranial aneurysm formation and progression by modulating vascular smooth muscle cell phenotype and function.
Shi Y; Li S; Song Y; Liu P; Yang Z; Liu Y; Quan K; Yu G; Fan Z; Zhu W
J Neuroinflammation; 2019 Oct; 16(1):185. PubMed ID: 31585542
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis.
Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J
Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428
[TBL] [Abstract][Full Text] [Related]
7. Publisher Correction to: Dexmedetomidine alleviates inflammatory response and oxidative stress injury of vascular smooth muscle cell via α2AR/GSK-3β/MKP-1/NRF2 axis in intracranial aneurysm.
Zhang Z; Mu X; Zhou X
BMC Pharmacol Toxicol; 2023 Jan; 24(1):4. PubMed ID: 36717902
[No Abstract] [Full Text] [Related]
8. Inhibition of TNFAIP1 ameliorates the oxidative stress and inflammatory injury in myocardial ischemia/reperfusion injury through modulation of Akt/GSK-3β/Nrf2 pathway.
Wen L; Yang QH; Ma XL; Li T; Xiao S; Sun CF
Int Immunopharmacol; 2021 Oct; 99():107993. PubMed ID: 34330059
[TBL] [Abstract][Full Text] [Related]
9. Lignans from Eucommia ulmoides Oliver leaves exhibit neuroprotective effects via activation of the PI3K/Akt/GSK-3β/Nrf2 signaling pathways in H
Han R; Yu Y; Zhao K; Wei J; Hui Y; Gao JM
Phytomedicine; 2022 Jul; 101():154124. PubMed ID: 35487038
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
11. Perilipin 5 protects against oxygen-glucose deprivation/reoxygenation-elicited neuronal damage by inhibiting oxidative stress and inflammatory injury via the Akt-GSK-3β-Nrf2 pathway.
Huo K; Ma KG; Guo QY; Duan P; Xu J
Int Immunopharmacol; 2022 Jul; 108():108718. PubMed ID: 35367744
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of epidermal growth factor receptor attenuates intracranial aneurysm formation by modulating the phenotype of vascular smooth muscle cells.
Luo Y; Tang H; Zhang Z; Zhao R; Wang C; Hou W; Huang Q; Liu J
CNS Neurosci Ther; 2022 Jan; 28(1):64-76. PubMed ID: 34729926
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats.
Zhang H; Sha J; Feng X; Hu X; Chen Y; Li B; Fan H
Int Immunopharmacol; 2019 Sep; 74():105717. PubMed ID: 31254953
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 inhibits intracranial aneurysm formation and progression in a mouse model.
Huang J; Zhang H; You L; Zhang J; Jiang Z
Pediatr Res; 2022 Mar; 91(4):839-845. PubMed ID: 33859365
[TBL] [Abstract][Full Text] [Related]
15. microRNA-331-3p maintains the contractile type of vascular smooth muscle cells by regulating TNF-α and CD14 in intracranial aneurysm.
Fan W; Liu Y; Li C; Qu X; Zheng G; Zhang Q; Pan Z; Wang Y; Rong J
Neuropharmacology; 2020 Mar; 164():107858. PubMed ID: 31785262
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134.
Li YJ; Zhang DZ; Xi Y; Wu CA
Hum Exp Toxicol; 2021 Dec; 40(12):2145-2155. PubMed ID: 34121490
[TBL] [Abstract][Full Text] [Related]
17. Glutaredoxin 1 protects neurons from oxygen-glucose deprivation/reoxygenation (OGD/R)-induced apoptosis and oxidative stress via the modulation of GSK-3β/Nrf2 signaling.
Qiu Z; Li X; Duan C; Li R; Han L
J Bioenerg Biomembr; 2021 Aug; 53(4):369-379. PubMed ID: 33956252
[TBL] [Abstract][Full Text] [Related]
18. Salvianolic Acid A Protects the Kidney against Oxidative Stress by Activating the Akt/GSK-3
Zhang HF; Wang JH; Wang YL; Gao C; Gu YT; Huang J; Wang JH; Zhang Z
Oxid Med Cell Longev; 2019; 2019():2853534. PubMed ID: 31011401
[TBL] [Abstract][Full Text] [Related]
19. Luteolin Alleviates Epithelial-Mesenchymal Transformation Induced by Oxidative Injury in ARPE-19 Cell
Chen L; Zhu Y; Zhou J; Wu R; Yang N; Bao Q; Xu X
Oxid Med Cell Longev; 2022; 2022():2265725. PubMed ID: 35198094
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine protects cells from Angiotensin II-induced smooth muscle cell phenotype switch and endothelial cell dysfunction.
Dai M; Zhu X; Zeng S; Liu Q; Hu R; Huang L; Wang Y; Deng J; Yu Q
Cell Cycle; 2023 Feb; 22(4):450-463. PubMed ID: 36196460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
